Figure 1

Kaplan–Meier analysis of CMV infection/reactivation-free duration. (a–h) CMV-related SNPs as revealed by end-point analysis were subject to Kaplan–Meier analysis. The CMV infection/reactivation-free status for recipients with the indicated genotype (panels a–c) or matched vs. not matched status for the donor and recipient genotype (panels d–h) was plotted against the follow-up period (month) after transplantation.